Join the Migraine group to help and get support from people like you.
Migraine News (Page 3)
Related terms: Migraine Headache, Hemiplegic Migraine, Complicated Migraine, Basilar-Type Migraine, Basilar Artery Migraine
Older Adults With Migraine Experienced Higher Depression Risk During Pandemic
TUESDAY, Nov. 26, 2024 – During the pandemic, older adults with migraine experienced a substantial increase in the risk for depression, regardless of previous history, than before the pandemic and...
FDA Approves Nerivio for Migraine Treatment in Children Aged 8 Years and Older
FRIDAY, Nov. 22, 2024 – The U.S. Food and Drug Administration has expanded the age indication for Nerivio, making it the first and only remote electrical neuromodulation (REN) wearable for migraine...
Clinical Practice Guideline Updated for Migraine, Tension-Type Headache
TUESDAY, Oct. 29, 2024 – In a clinical practice guideline (CPG) issued by the U.S. Department of Veterans Affairs and U.S. Department of Defense and published online Oct. 29 in the Annals of...
Study Addresses Differentiating Meniere Disease, Vestibular Migraine
THURSDAY, Oct. 3, 2024 – The dissociation between pathological caloric testing and a normal video head impulse test can differentiate between Meniere disease (MD) and vestibular migraine (VM),...
Review Compares Drug Interventions for Acute Migraine Treatment
MONDAY, Sept. 23, 2024 – All active interventions show superior efficacy to placebo for freedom from pain, and most do for sustained pain freedom, for the acute treatment of migraine among adults,...
Erenumab Effective for Nonopioid Medication Overuse Headache in Chronic Migraine
WEDNESDAY, Sept. 18, 2024 – Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in patients with nonopioid chronic migraine...
FDA Medwatch Alert: Aurobindo Pharma USA, Inc. on Behalf of AuroHealth, Issues Recall of One Lot of Healthy Living Over the Counter (OTC) Migraine Relief
July 18, 2024 – East Windsor, New Jersey. Aurobindo Pharma USA, Inc., on behalf of AuroHealth, is voluntarily recalling one lot (refer table below) of Healthy Living Migraine Relief, Acetaminophen 2...
FDA Approves RizaFilm (rizatriptan) Oral Film for the Treatment of Acute Migraine
SAINT LAURENT, Quebec, April 17, 2023 (GLOBE NEWSWIRE) – IntelGenx Corp. (TSX:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx"), a leader in pharmaceutical films, today announced that the U.S. Food...
U.S. FDA Approves Qulipta (atogepant) for Adults With Chronic Migraine
NORTH CHICAGO, Ill., April 17, 2023 /PRNewswire/ – AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved expanding the indication of Qulipta (atogepant) ...
FDA Approves Zavzpret (zavegepant) Nasal Spray for the Acute Treatment of Migraine
NEW YORK--(BUSINESS WIRE) March 10, 2023 – Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved Zavzpret (zavegepant), the first and only calcitonin...
FDA Approves Trudhesa (dihydroergotamine mesylate) Nasal Spray for the Acute Treatment of Migraine
SEATTLE, Sept. 03, 2021 (GLOBE NEWSWIRE) – Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for people suffering from diseases...
FDA Approves Biohaven's Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now the only migraine medication approved to both treat acute migraine attacks and help prevent...
FDA Approves Elyxyb (celecoxib) Oral Solution For Acute Treatment Of Migraine With Or Without Aura In Adults
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE) May 06, 2020 --Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced approval of Elyxyb ...
FDA Approves Nurtec ODT (rimegepant) for the Acute Treatment of Migraine in Adults
NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ – Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved Nurtec ODT...
Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm) Injection Autoinjector
PARSIPPANY, N.J.--(BUSINESS WIRE) January 28, 2020 – Teva Pharmaceuticals USA, Inc. an affiliate ofTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that the Food and Drug...
Further information
Related condition support groups
Migraine Prevention, Migraine Prophylaxis, Chronic Migraine, Headache
Related drug support groups
gabapentin, ibuprofen, amitriptyline, venlafaxine, propranolol, diclofenac, cyclobenzaprine, topiramate, Botox, view more... sumatriptan, Excedrin, Imitrex, Ubrelvy, Excedrin Migraine, erenumab, cyproheptadine, verapamil, Reglan, Migraine Relief, Nurtec ODT